Drug Shortage Report for NORDIMET
| Report ID | 274788 |
| Drug Identification Number | 02546574 |
| Brand name | NORDIMET |
| Common or Proper name | METHOTREXATE (METHOTREXATE SODIUM) 15 mg/0.6 ml |
| Company Name | NORDIC GROUP B.V. |
| Market Status | MARKETED |
| Active Ingredient(s) | METHOTREXATE |
| Strength(s) | 15MG |
| Dosage form(s) | SOLUTION |
| Route of administration | SUBCUTANEOUS |
| Packaging size | 1 pre-filled auto-injector pen |
| ATC code | L04AX |
| ATC description | IMMUNOSUPPRESSANTS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | 2026-03-31 |
| Actual start date | |
| Estimated end date | Unknown |
| Actual end date | |
| Shortage status | Anticipated shortage |
| Updated date | 2025-12-19 |
| Company comments | This strength of the product is not currently available in Canada. The status of this presentation may be re-evaluated in the future based on various factors. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | SIRIUSDREEF 41 HOOFDDORP, NOORD-HOLLAND NETHERLANDS 2132 WT |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2025-12-19 | English | Compare |
| v3 | 2025-12-19 | English | Compare |
| v2 | 2025-12-19 | French | Compare |
| v1 | 2025-12-19 | English | Compare |
Showing 1 to 4 of 4